Uncategorized

May 13, 2025

Emollient for prevention of eczema

Article:  Lancet. 2020 Mar 21;395(10228):962-972. "Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial" Reviewer: Dr. Tyler Emery 

Feb. 11, 2025

Propranolol vs Atenolol in Infants with Hemangioma

Article:  JAMA otolaryngology-- head & neck surgery. 2021 Jul 1;147(7):599-607. "Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas." Reviewer: Dr. Zainab Khan

Jan. 14, 2025

Midline vs. Peripheral IV Catheters in Longer Term Pediatric Patients

Article: JAMA Pediatrics. 2023 Nov 1;177(11):1132-1140. "Midline Compared With Peripheral Intravenous Catheters for Therapy of 4 Days or Longer in Pediatric Patients. A Randomized Clinical Trial" Reviewer: Dr. Ben Legere

April 23, 2024

Dupilumab for Eosinophilic Esophagitis

Article: Lancet Gastroenterol Hepatol. 2023 Nov;8(11):990-1004. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Reviewer: Dr. Kelly Squires

March 19, 2024

Brentuximab Vedotin for Hodgkin’s Lymphoma

Article: N Engl J Med. 2022 Nov 3;387(18):1649-1660. Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma Reviewer: Dr. Asba Memon

March 5, 2024

Omalizumab for food allergies

Article: N Engl J Med. 2024 Mar 7;390(10):889-899 Omalizumab for the Treatment of Multiple Food Allergies Reviewer: Dr. Myranda Grismore  

Feb. 6, 2024

Voxelotor for sickle cell disease

Article: Lancet Haematol. 2021 May;8(5):e306-e307. PMID: 33838114 Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial. Reviewer: Dr. Ezgi Atilgan

June 20, 2023

Extended half-life rFVIIIFc for previously untreated hemophilia A

Article: Blood. 2022 Jun 30;139(26):3699-3707. First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results Reviewer: Dr. Aaron Stafford

May 16, 2023

Rituximab for Non-Hodgkin’s Lymphoma

Article: N Engl J Med. 2020 Jun 4;382(23):2207-2219. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children Reviewer: Dr. Cassidy Caballero

Feb. 28, 2023

Exercise for diabetes risk reduction in children

Article: JAMA. 2012 Sep 19;308(11):1103-12. Exercise dose and diabetes risk in overweight and obese children: A RCT Reviewer: Dr. Anna Davis